4//SEC Filing
Edge Therapeutics, Inc. 4
Accession 0001140361-16-054010
$PDSBCIK 0001472091operating
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 6:49 PM ET
Size
5.5 KB
Accession
0001140361-16-054010
Insider Transaction Report
Form 4
Macdonald R. Loch
DirectorChief Scientific Officer
Transactions
- Award
Stock Option (Right to Purchase)
2016-02-16+85,000→ 85,000 totalExercise: $6.99Exp: 2026-02-16→ Common Stock (85,000 underlying)
Footnotes (1)
- [F1]This option, representing a right to purchase a total of 85,000 shares of Common Stock, will become exercisable on February 16, 2017, with 25% vesting on that date and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date.
Documents
Issuer
Edge Therapeutics, Inc.
CIK 0001472091
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001472091
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 6:49 PM ET
- Size
- 5.5 KB